Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$43.78 - $63.86 $1.53 Million - $2.24 Million
35,000 Added 53.85%
100,000 $5.02 Million
Q4 2023

Feb 14, 2024

BUY
$36.35 - $63.02 $2.36 Million - $4.1 Million
65,000 New
65,000 $3.93 Million

Others Institutions Holding MLTX

About MoonLake Immunotherapeutics


  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.74B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Blue Owl Capital Holdings LP Portfolio

Follow Blue Owl Capital Holdings LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Owl Capital Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Owl Capital Holdings LP with notifications on news.